what are compounded glp 1 drugs New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these at scale. Our Fight over GLP-1 compounding plays

PRIN: PROGETTI DI RICERCA DI RILEVANTE INTERESSE NAZIONALE / Bando 2022 Prot

Y.PatelS

The FDA allows the compounding of certain drugs if the commercially available version is in a verified shortage , which they define as a period of time when the demand or projected demand for the drug within the United States exceeds the supply of the drug. Although there is no exact threshold, this decision is usually based on disruptions in manufacturing and distribution as well as unexpected demand surges

Buscail E, Deraison C

(PubMed) Brooks JO, 3rd, Yesavage JA, Carta A, Bravi D

Research Protocols and Dosage Guidelines FOXO4-DRI is strictly a research compound